Director, Screening Platform Technology at Revolution Medicines

You're a seasoned leader with a scientific background and at least 5 years of experience (PhD preferred) managing teams and hands-on expertise in high-throughpu

Work type: hybrid

Location: Redwood City, California, United States

Salary: $211,000 – $264,000/yr

Type: Full-time

Summary

You're a seasoned leader with a scientific background and at least 5 years of experience (PhD preferred) managing teams and hands-on expertise in high-throughput screening platforms and data analytics, ideally within a drug discovery setting. **What makes it worth a look...** Revolution Medicines is offering a full-time, hybrid role at their Redwood City, California headquarters with a substantial annual salary of USD 211,000 - 264,000. **You might be a good fit if you...** * Hold a Bachelor's degree in Chemistry or related field, or a Master's or PhD with the specified years of experience. * Have extensive experience designing, implementing, and operating HTS platforms, integrating robotics, software, and data pipelines. * Possess direct expertise in screening data analytics, including statistical analysis, quality control, and experimental design, with experience in AI/ML approaches.

Job Description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

We are seeking an experienced Director of Screening Platform Technology to lead a multidisciplinary team responsible for the design, execution, and evolution of Revolution Medicines’ screening platforms. This role will oversee assay operations, new process implementation, and screening analytics and controls, and will partner closely with software engineers, automation engineers, and a cross-functional screening strategy taskforce. The successful candidate will bring strong people leadership, deep experience in high-throughput screening platforms, and direct technical expertise in screening analytics and data-driven experimental design.

• Lead and develop a team of approximately 7–10 scientists and technical staff across assay operations, new process implementation, and screening analytics and controls.

• Provide strategic and technical leadership for HTS platform development in close partnership with software engineering, automation engineering, and cross-functional stakeholders.

• Own the end-to-end screening platform, ensuring robust integration of robotics, instrumentation, software, and data pipelines.

• Drive adoption of advanced screening analytics, including quality control frameworks, longitudinal analysis across campaigns, and AI-enabled or data-driven experimental design.

• Serve as a technical thought partner to discovery teams, translating scientific questions into effective screening strategies and interpretable data outputs.

• Establish best practices for screening data integrity, reproducibility, and insight generation.

• Serve as the primary point of contact for cross-functional partners, ensuring timely and accurate delivery of materials.

• Work closely with the Director of Sample Management to communicate capacity, risks, and resource needs.

• Support onboarding and ramp-up of new staff and technologies within the laboratory.

• Bachelor’s degree in Chemistry or a related field with a minimum of 8 years of relevant experience, Master’s degree with at least 6 years of relevant experience, or Ph.D. with a minimum of 5 years of relevant experience; a combination of direct and related industry experience is preferred.

• Demonstrated success leading and developing multidisciplinary teams, including experience managing sub-team leads or senior contributors.

• Extensive experience designing, implementing, and operating HTS platforms in collaboration with automation and software engineering teams.

• Direct, hands-on expertise in screening data analytics, including statistical analysis, controls, longitudinal data analysis, and experimental design.

• Experience applying or evaluating machine learning or AI-driven approaches to screening strategy and data interpretation.

• Strong systems-level thinking with the ability to balance innovation with pragmatic delivery of results.

• Excellent written and verbal communication skills.

• Experience shaping or modernizing screening platforms in a growing discovery organization.

• Familiarity with scalable data and analytics frameworks for screening and discovery.

• Oncology or small-molecule drug discovery experience.

The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.

Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

View this job on nocollar jobs